Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis
View abstract on PubMed
Summary
This summary is machine-generated.Speckle-type POZ (SPOP) gene mutations are linked to better outcomes in prostate cancer (PC). SPOP-mutant PC patients show improved survival, suggesting tailored treatments may be beneficial.
Area Of Science
- Oncology
- Genetics
- Prostate Cancer Research
Background
- Mutations in the speckle-type POZ (SPOP) gene are common in prostate cancer (PC).
- The prognostic significance and optimal treatment strategies for SPOP-mutant PC (SPOPmut PC) remain unclear.
- Limited consensus exists on tailored treatments for SPOPmut PC.
Purpose Of The Study
- To determine the prognostic and predictive value of SPOP mutations in distinct stages and treatments of PC.
- To compare survival outcomes between SPOP-mutant (SPOPmut) and SPOP wild-type (SPOPwt) prostate cancer patients.
Main Methods
- A systematic literature search was performed across PubMed, Embase, and Scopus databases.
- A meta-analysis was conducted on 26 studies, comparing survival outcomes between SPOPmut and SPOPwt PC.
- Survival endpoints analyzed included metastasis-free survival, progression-free survival, and overall survival.
Main Results
- SPOP mutations were associated with a favorable prognosis in localized and metastatic PC.
- Patients with SPOPmut PC showed improved metastasis-free survival and overall survival (OS).
- In metastatic settings, SPOP mutations correlated with better progression-free survival (PFS) and OS with androgen deprivation therapy ± androgen receptor signaling inhibitors; abiraterone showed benefit in metastatic castration-resistant PC, but docetaxel did not.
Conclusions
- SPOP mutations may serve as a favorable prognostic factor in prostate cancer.
- Patients with SPOPmut PC appear to have superior oncological outcomes compared to SPOPwt PC.
- Further research into tailored risk stratification and treatment approaches for SPOPmut PC is warranted.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

